CliffBio
small molecule

TIMOLOL MALEATE

TIMOLOL MALEATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameTIMOLOL MALEATE
Active ingredientTIMOLOL MALEATE
StrengthEQ 0.5% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalApril 2015
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.